Eur Rev Med Pharmacol Sci 2017; 21 (7): 1645-1652

Controlled, prospective, observational study on the efficiency and tolerability of a combination of potential Nrf2-inducing antioxidants and micronutrients as pre-treatment for ICSI in dyspermic patients with previous failure

R. Rago, M. Gallo, A. Dal Lago, E. Licata, G. Paciotti, M. Amodei, C. Meneghini, C. Fabiani, G. Dani, C. Liberanome, D. Antonaci, R. Corno, D. Miriello, G. Giuffrida, B. Giammusso

Physiopathology of Reproduction and Andrology Unit, Sandro Pertini Hospital, Rome, Italy. rocco.rago@aslroma2.it


OBJECTIVE: To evaluate the efficiency of pre-treatment in dyspermic males in IVF couples with a combination of micronutrients, for the purpose of improving the fertilization rate, the implantation rate and the outcome of the pregnancy.

PATIENTS AND METHODS: This controlled prospective clinical study was performed in two medically assisted reproduction centers. 59 males with mild oligo-astheno-teratospermia (OAT) were admitted to the study. All of them had a history of previous in vitro fertilization (IVF) attempts with female partners aged < 40 diagnosed having tubal or idiopathic infertility. The subjects upon enrolment underwent a semen test and afterward were treated with alpha lipoic acid and glutathione (Fertiplus SOD®, Idi-Pharma, Catania, Italy) for 4 weeks (short-term). The primary endpoints that were evaluated are the following: fertilization rate (mean fertilization), implantation rate and pregnancy rate.

RESULTS: At the end of this study all the males (mean age 39.5 ± 5.1) reported in not having any side effects during the administration of Fertiplus. Their female partners (mean age 34.9 ± 4.5) underwent IVF using the ICSI technique. The number of oocytes retrieved and inseminated was not statistically different in comparison to previous attempts, but with the same number of oocytes treated, the fertilization rate per couple demonstrated statistically significant increase (p<0.001). We did not observe a percentage increase in evolutionary embryos, but we noticed an improvement in embryo quality per individual couple (p<0.001), associated with a net increase in the implantation rate per couple (p<0.001) in terms of clinical pregnancy. The estimated miscarriage risk after treatment was five times lower (p<0.001).

CONCLUSIONS: Short-term treatment with micronutrients in dyspermic subjects can improve the reproductive outcome of the IVF procedure.

Free PDF Download

To cite this article

R. Rago, M. Gallo, A. Dal Lago, E. Licata, G. Paciotti, M. Amodei, C. Meneghini, C. Fabiani, G. Dani, C. Liberanome, D. Antonaci, R. Corno, D. Miriello, G. Giuffrida, B. Giammusso
Controlled, prospective, observational study on the efficiency and tolerability of a combination of potential Nrf2-inducing antioxidants and micronutrients as pre-treatment for ICSI in dyspermic patients with previous failure

Eur Rev Med Pharmacol Sci
Year: 2017
Vol. 21 - N. 7
Pages: 1645-1652